Abstract Submission Guidelines for Invited Speakers

Abstract Preparation The abstract should be in English, typed, and single-spaced using Times New Roman font at size 11.The entire abstract should fit within the box provided in the abstract form. The title should be in BOLD letters. The full name (first, middle initial, and last), affiliation, and country of each author should be indicated. The name of the presenting author should be underlined. Do not indent paragraphs. Skip a line between paragraphs. Sample abstract A prospective study of HLA-B*1502 genotyping in preventing carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis Pei Chen1, Chen-Yang Shen1, Juei-Jueng Lin2, Cheung-Ter Ong3, Shey-Lin Wu4, Yuan-Tsong Chen1, and Taiwan SJS consortium. 1Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; 2Chu Shang Show Chwan Hospital, Nan-tou, Taiwan; 3Chia-Yi Christian Hospital, Chia-Yi, Taiwan; 4Changhua Christian Hospital, Chang-Hua, Taiwan. tevens-Johnson syndrome (SJS) and its related disease toxic epidermal necrolysis (TEN) are two of the most serious adverse reactions caused by drugs. Carbamazepine (CBZ), used primarily in the treatment of epilepsy and bipolar disorder, is the commonest cause of SJS/TEN in Abstract Submission The abstract form can be downloaded from the website of the Conference (http://taiwan-acga2010.ibms.sinica.edu.tw).Save your finished abstract form as a doc. file and email it to the Secretariat of Conference at yhwang74@ibms.sinica.edu.tw by February 28, 2010.